Other Diagnoses, Comorbidities, and Complications
8
0
0
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
12.5%
1 terminated out of 8 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (8)
UTSW Depression Cohort: A Longitudinal Study of Depression
Hartmanns Procedure or Abdominoperineal Excision With Intersphincteric Dissection in Rectal Cancer: a Randomized Study
Early Detection of COPD Patients in GOLD 0 (Smokers) Population
Multi-PAP: Improving Prescription in Primary Care Patients With Multimorbidity and Polypharmacy
Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life
Assessing the Efficacy of an Electronic Discharge Communication Tool
Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment
Respiratory Muscle Training in Institutionalized Elderly Population